{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T23:39:54Z","timestamp":1792798794376,"version":"4.5.0"},"reference-count":124,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T00:00:00Z","timestamp":1792713600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T00:00:00Z","timestamp":1792713600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"DOI":"10.13039\/501100003725","name":"National Research Foundation of Korea","doi-asserted-by":"publisher","award":["RS-2024-00338184"],"award-info":[{"award-number":["RS-2024-00338184"]}],"id":[{"id":"10.13039\/501100003725","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003725","name":"National Research Foundation of Korea","doi-asserted-by":"publisher","award":["RS-2026-25599399"],"award-info":[{"award-number":["RS-2026-25599399"]}],"id":[{"id":"10.13039\/501100003725","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003725","name":"National Research Foundation of Korea","doi-asserted-by":"publisher","award":["RS-2026-25504778"],"award-info":[{"award-number":["RS-2026-25504778"]}],"id":[{"id":"10.13039\/501100003725","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Curr Oncol Rep"],"DOI":"10.1007\/s11912-026-01849-5","type":"journal-article","created":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T10:10:21Z","timestamp":1792750221000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Ketamine Beyond Anaesthesia: Analgesic, Psychiatric, Antitumour, and Immunomodulatory Actions and Their Signalling Mechanisms"],"prefix":"10.1007","volume":"28","author":[{"given":"Kihwan","family":"Lee","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jung Hoon","family":"Jung","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joseph","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jin Woo","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chul-Ho","family":"Jeong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eui-Jun","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sooyeun","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,10,23]]},"reference":[{"key":"1849_CR1","doi-asserted-by":"publisher","first-page":"1691","DOI":"10.2147\/JPR.S360733","volume":"15","author":"SJ Drozdz","year":"2022","unstructured":"Drozdz SJ, Goel A, McGarr MW, Katz J, Ritvo P, Mattina G, et al. Ketamine Assisted Psychotherapy: A Systematic Narrative Review of the Literature. JPR. 2022;15:1691\u2013706. https:\/\/doi.org\/10.2147\/JPR.S360733.","journal-title":"JPR"},{"key":"1849_CR2","doi-asserted-by":"publisher","unstructured":"Li L, Vlisides PE Ketamine: 50 years of modulating the mind. Front Hum Neurosci [Internet]. 2016;10. [cited 2025 Aug 7]; https:\/\/doi.org\/10.3389\/fnhum.2016.00612.","DOI":"10.3389\/fnhum.2016.00612"},{"key":"1849_CR3","unstructured":"U.S. Food and Drug Administration. KETALAR (ketamine hydrochloride) FDA Label [Internet]. Web Page. U.S. Food and Drug Administration; 2020. https:\/\/www.accessdata.fda.gov\/drugsatfda_docs\/label\/2020\/016812s046lbl.pdf."},{"key":"1849_CR4","doi-asserted-by":"publisher","first-page":"903","DOI":"10.1097\/00000542-199704000-00021","volume":"86","author":"BA Orser","year":"1997","unstructured":"Orser BA, Pennefather PS, MacDonald JF. Multiple Mechanisms of Ketamine Blockade of N-methyl-D-aspartate Receptors. Anesthesiology. 1997;86:903\u201317. https:\/\/doi.org\/10.1097\/00000542-199704000-00021.","journal-title":"Anesthesiology"},{"key":"1849_CR5","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1038\/s41386-023-01632-1","volume":"49","author":"JN Johnston","year":"2024","unstructured":"Johnston JN, Kadriu B, Kraus C, Henter ID, Zarate CA. Ketamine in neuropsychiatric disorders: an update. Neuropsychopharmacol. 2024;49:23\u201340. https:\/\/doi.org\/10.1038\/s41386-023-01632-1.","journal-title":"Neuropsychopharmacol"},{"key":"1849_CR6","doi-asserted-by":"publisher","first-page":"704","DOI":"10.1097\/00000542-199004000-00021","volume":"72","author":"T Yamamura","year":"1990","unstructured":"Yamamura T, Harada K, Okamura A, Kemmotsu O. Is the Site of Action of Ketamine Anesthesia the N-Methyl-D-Aspartate Receptor? Anesthesiology. 1990;72:704\u201310. https:\/\/doi.org\/10.1097\/00000542-199004000-00021.","journal-title":"Anesthesiology"},{"key":"1849_CR7","doi-asserted-by":"publisher","first-page":"109164","DOI":"10.1016\/j.cbi.2020.109164","volume":"327","author":"L-H Sun","year":"2020","unstructured":"Sun L-H, Fan Y-Y, Wang X, Zheng H-B. Pharmacodynamic elucidation of glutamate & dopamine in ketamine-induced anaesthesia. Chemico-Biol Interact. 2020;327:109164. https:\/\/doi.org\/10.1016\/j.cbi.2020.109164.","journal-title":"Chemico-Biol Interact"},{"key":"1849_CR8","doi-asserted-by":"publisher","first-page":"e656","DOI":"10.1136\/bmjspcare-2018-001739","volume":"12","author":"M Courade","year":"2022","unstructured":"Courade M, Bertrand A, Guerrini-Rousseau L, Pagnier A, Levy D, Lervat C, et al. Low-dose ketamine adjuvant treatment for refractory pain in children, adolescents and young adults with cancer: a pilot study. BMJ Support Palliat Care. 2022;12:e656\u201363. https:\/\/doi.org\/10.1136\/bmjspcare-2018-001739.","journal-title":"BMJ Support Palliat Care"},{"key":"1849_CR9","doi-asserted-by":"publisher","first-page":"246","DOI":"10.1016\/S0885-3924(00)00194-9","volume":"20","author":"S Mercadante","year":"2000","unstructured":"Mercadante S, Arcuri E, Tirelli W, Casuccio A. Analgesic Effect of Intravenous Ketamine in Cancer Patients on Morphine Therapy. J Pain Symptom Manag. 2000;20:246\u201352. https:\/\/doi.org\/10.1016\/S0885-3924(00)00194-9.","journal-title":"J Pain Symptom Manag"},{"key":"1849_CR10","doi-asserted-by":"publisher","first-page":"116516","DOI":"10.1016\/j.bcp.2024.116516","volume":"229","author":"T Magruder","year":"2024","unstructured":"Magruder T, Isenhart M, Striepe MV, Mannisto A, Jannie KM, Smith J, et al. Ketamine \u2013 Imperfect Wonder Drug? Biochem Pharmacol. 2024;229:116516. https:\/\/doi.org\/10.1016\/j.bcp.2024.116516.","journal-title":"Ketamine \u2013 Imperfect Wonder Drug? Biochem Pharmacol"},{"key":"1849_CR11","doi-asserted-by":"publisher","first-page":"104164","DOI":"10.1016\/j.ajp.2024.104164","volume":"99","author":"K Ishii","year":"2024","unstructured":"Ishii K, Okita K. Potential effect of ketamine in treatment for dextromethorphan use disorder exploding in Japanese young population. Asian J Psychiatry. 2024;99:104164. https:\/\/doi.org\/10.1016\/j.ajp.2024.104164.","journal-title":"Asian J Psychiatry"},{"key":"1849_CR12","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1016\/j.pbb.2013.11.033","volume":"116","author":"J Zhang","year":"2014","unstructured":"Zhang J, Li S, Hashimoto K. R (\u2013)-ketamine shows greater potency and longer lasting antidepressant effects than S (+)-ketamine. Pharmacol Biochem Behav. 2014;116:137\u201341. https:\/\/doi.org\/10.1016\/j.pbb.2013.11.033.","journal-title":"Pharmacol Biochem Behav"},{"key":"1849_CR13","doi-asserted-by":"publisher","first-page":"1059","DOI":"10.1007\/s40262-016-0383-6","volume":"55","author":"MA Peltoniemi","year":"2016","unstructured":"Peltoniemi MA, Hagelberg NM, Olkkola KT, Saari TI, Ketamine. A Review of Clinical Pharmacokinetics and Pharmacodynamics in Anesthesia and Pain Therapy. Clin Pharmacokinet. 2016;55:1059\u201377. https:\/\/doi.org\/10.1007\/s40262-016-0383-6.","journal-title":"Clin Pharmacokinet"},{"key":"1849_CR14","doi-asserted-by":"publisher","first-page":"481","DOI":"10.1038\/nature17998","volume":"533","author":"P Zanos","year":"2016","unstructured":"Zanos P, Moaddel R, Morris PJ, Georgiou P, Fischell J, Elmer GI, et al. NMDAR inhibition-independent antidepressant actions of ketamine metabolites. Nature. 2016;533:481\u20136. https:\/\/doi.org\/10.1038\/nature17998.","journal-title":"Nature"},{"key":"1849_CR15","doi-asserted-by":"publisher","first-page":"1228895","DOI":"10.3389\/fphar.2023.1228895","volume":"14","author":"J Zhou","year":"2023","unstructured":"Zhou J, Peng G, Liang W, Chen Z, Liu Y, Wang B, et al. Recent advances in the study of anesthesia-and analgesia-related mechanisms of S-ketamine. Front Pharmacol. 2023;14:1228895. https:\/\/doi.org\/10.3389\/fphar.2023.1228895.","journal-title":"Front Pharmacol"},{"key":"1849_CR16","doi-asserted-by":"publisher","first-page":"e632","DOI":"10.1038\/tp.2015.136","volume":"5","author":"C Yang","year":"2015","unstructured":"Yang C, Shirayama Y, Zhang J, Ren Q, Yao W, Ma M, et al. R-ketamine: a rapid-onset and sustained antidepressant without psychotomimetic side effects. Transl Psychiatry. 2015;5:e632\u2013632. https:\/\/doi.org\/10.1038\/tp.2015.136.","journal-title":"Transl Psychiatry"},{"key":"1849_CR17","doi-asserted-by":"publisher","first-page":"1274","DOI":"10.1097\/00000542-199512000-00018","volume":"83","author":"M Yamakage","year":"1995","unstructured":"Yamakage M, Hirshman CA, Croxton TL. Inhibitory Effects of Thiopental, Ketamine, and Propofol on Voltage-dependent Calcium sup 2\u2009+\u2009Channels in Porcine Tracheal Smooth Muscle Cells. Anesthesiology. 1995;83:1274\u201382. https:\/\/doi.org\/10.1097\/00000542-199512000-00018.","journal-title":"Anesthesiology"},{"key":"1849_CR18","doi-asserted-by":"publisher","first-page":"600","DOI":"10.1523\/JNEUROSCI.3481-08.2009","volume":"29","author":"X Chen","year":"2009","unstructured":"Chen X, Shu S, Bayliss DA. HCN1 Channel Subunits Are a Molecular Substrate for Hypnotic Actions of Ketamine. J Neurosci. 2009;29:600\u20139. https:\/\/doi.org\/10.1523\/JNEUROSCI.3481-08.2009.","journal-title":"J Neurosci"},{"key":"1849_CR19","doi-asserted-by":"publisher","DOI":"10.1213\/00000539-199112000-00022","author":"VC Baum","year":"1991","unstructured":"Baum VC, Tecson ME. Ketamine Inhibits Transsarcolemmal Calcium Entry in Guinea Pig Myocardium: Direct Evidence by Single Cell Voltage Clamp. Anesth Analgesia. 1991. https:\/\/doi.org\/10.1213\/00000539-199112000-00022. 73:804???807.","journal-title":"Anesth Analgesia"},{"key":"1849_CR20","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1016\/j.brainres.2014.03.026","volume":"1562","author":"DDF Pacheco","year":"2014","unstructured":"Pacheco DDF, Romero TRL, Duarte IDG. Central antinociception induced by ketamine is mediated by endogenous opioids and \u00b5- and \u03b4-opioid receptors. Brain Res. 2014;1562:69\u201375. https:\/\/doi.org\/10.1016\/j.brainres.2014.03.026.","journal-title":"Brain Res"},{"key":"1849_CR21","doi-asserted-by":"publisher","first-page":"17370","DOI":"10.1523\/JNEUROSCI.4152-11.2011","volume":"31","author":"Y Hayashi","year":"2011","unstructured":"Hayashi Y, Kawaji K, Sun L, Zhang X, Koyano K, Yokoyama T, et al. Microglial Ca2+ -Activated K+ Channels Are Possible Molecular Targets for the Analgesic Effects of S -Ketamine on Neuropathic Pain. J Neurosci. 2011;31:17370\u201382. https:\/\/doi.org\/10.1523\/JNEUROSCI.4152-11.2011.","journal-title":"J Neurosci"},{"key":"1849_CR22","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1016\/j.pscychresns.2015.06.001","volume":"233","author":"CI Rodriguez","year":"2015","unstructured":"Rodriguez CI, Kegeles LS, Levinson A, Ogden RT, Mao X, Milak MS, et al. In vivo effects of ketamine on glutamate-glutamine and gamma-aminobutyric acid in obsessive-compulsive disorder: Proof of concept. Psychiatry Research: Neuroimaging. 2015;233:141\u20137. https:\/\/doi.org\/10.1016\/j.pscychresns.2015.06.001.","journal-title":"Psychiatry Research: Neuroimaging"},{"key":"1849_CR23","doi-asserted-by":"publisher","unstructured":"Tan S, Rudd JA, Yew DT. Gene expression changes in GABAA receptors and cognition following chronic Ketamine administration in mice. McAlonan GM, editor. PLoS ONE. 2011;6:e21328. https:\/\/doi.org\/10.1371\/journal.pone.0021328","DOI":"10.1371\/journal.pone.0021328"},{"key":"1849_CR24","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1016\/j.pnpbp.2013.11.003","volume":"51","author":"SA Perrine","year":"2014","unstructured":"Perrine SA, Ghoddoussi F, Michaels MS, Sheikh IS, McKelvey G, Galloway MP. Ketamine reverses stress-induced depression-like behavior and increased GABA levels in the anterior cingulate: An 11.7T 1H-MRS study in rats. Prog Neuropsychopharmacol Biol Psychiatry. 2014;51:9\u201315. https:\/\/doi.org\/10.1016\/j.pnpbp.2013.11.003.","journal-title":"Prog Neuropsychopharmacol Biol Psychiatry"},{"key":"1849_CR25","doi-asserted-by":"publisher","first-page":"720","DOI":"10.1016\/j.jad.2024.01.202","volume":"351","author":"S Li","year":"2024","unstructured":"Li S, Zhou W, Li P, Lin R. Effects of ketamine and esketamine on preventing postpartum depression after cesarean delivery: A meta-analysis. J Affect Disord. 2024;351:720\u20138. https:\/\/doi.org\/10.1016\/j.jad.2024.01.202.","journal-title":"J Affect Disord"},{"key":"1849_CR26","doi-asserted-by":"publisher","first-page":"733","DOI":"10.3389\/fphar.2018.00733","volume":"9","author":"EE Schenberg","year":"2018","unstructured":"Schenberg EE, Psychedelic-Assisted Psychotherapy. A Paradigm Shift in Psychiatric Research and Development. Front Pharmacol. 2018;9:733. https:\/\/doi.org\/10.3389\/fphar.2018.00733.","journal-title":"Front Pharmacol"},{"key":"1849_CR27","doi-asserted-by":"publisher","first-page":"72","DOI":"10.1016\/j.neuropharm.2018.01.017","volume":"142","author":"I Ivan Ezquerra-Romano","year":"2018","unstructured":"Ivan Ezquerra-Romano I, Lawn W, Krupitsky E, Morgan CJA. Ketamine for the treatment of addiction: Evidence and potential mechanisms. Neuropharmacology. 2018;142:72\u201382. https:\/\/doi.org\/10.1016\/j.neuropharm.2018.01.017.","journal-title":"Neuropharmacology"},{"key":"1849_CR28","doi-asserted-by":"publisher","first-page":"103","DOI":"10.4097\/kja.20663","volume":"74","author":"A Kumar","year":"2021","unstructured":"Kumar A, Kohli A. Comeback of ketamine: resurfacing facts and dispelling myths. Korean J Anesthesiol. 2021;74:103\u201314. https:\/\/doi.org\/10.4097\/kja.20663.","journal-title":"Korean J Anesthesiol"},{"key":"1849_CR29","doi-asserted-by":"publisher","first-page":"53759","DOI":"10.12775\/QS.2024.18.53759","volume":"18","author":"A Kaptur","year":"2024","unstructured":"Kaptur A, Dziedzi\u0144ski D, \u0141o\u015b D, Nowak A, Janus A, Kwa\u015bniewska O. Clinical applications of ketamine: a literature review. Qual Sport. 2024;18:53759. https:\/\/doi.org\/10.12775\/QS.2024.18.53759.","journal-title":"Qual Sport"},{"key":"1849_CR30","doi-asserted-by":"publisher","first-page":"283","DOI":"10.4103\/0259-1162.143110","volume":"8","author":"M Kurdi","year":"2014","unstructured":"Kurdi M, Theerth K, Deva R, Ketamine. Current applications in anesthesia, pain, and critical care. Anesth Essays Res. 2014;8:283. https:\/\/doi.org\/10.4103\/0259-1162.143110.","journal-title":"Anesth Essays Res"},{"key":"1849_CR31","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1007\/s00540-013-1657-x","volume":"28","author":"P Gyanesh","year":"2014","unstructured":"Gyanesh P, Haldar R, Srivastava D, Agrawal PM, Tiwari AK, Singh PK. Comparison between intranasal dexmedetomidine and intranasal ketamine as premedication for procedural sedation in children undergoing MRI: a double-blind, randomized, placebo-controlled trial. J Anesth. 2014;28:12\u20138. https:\/\/doi.org\/10.1007\/s00540-013-1657-x.","journal-title":"J Anesth"},{"key":"1849_CR32","doi-asserted-by":"publisher","first-page":"94","DOI":"10.1097\/TA.0b013e318250cdb8","volume":"73","author":"NJ Smischney","year":"2012","unstructured":"Smischney NJ, Beach ML, Loftus RW, Dodds TM, Koff MD. Ketamine\/propofol admixture (ketofol) is associated with improved hemodynamics as an induction agent: A randomized, controlled trial. J Trauma Acute Care Surg. 2012;73:94\u2013101. https:\/\/doi.org\/10.1097\/TA.0b013e318250cdb8.","journal-title":"J Trauma Acute Care Surg"},{"key":"1849_CR33","doi-asserted-by":"publisher","first-page":"952","DOI":"10.2174\/138945012800675713","volume":"13","author":"V Mossetti","year":"2012","unstructured":"Mossetti V, Vicchio N, Ivani G. Local Anesthetis and Adjuvants in Pediatric Regional Anesthesia. CDT. 2012;13:952\u201360. https:\/\/doi.org\/10.2174\/138945012800675713.","journal-title":"CDT"},{"key":"1849_CR34","doi-asserted-by":"publisher","unstructured":"Xu Z, Zhang J, Shen H, Zheng J. Assessment of pulse oximeter perfusion index in pediatric caudal block under basal Ketamine anesthesia. Lang S, Martin EO, editors. The Scientific World Journal. 2013;2013:183493. https:\/\/doi.org\/10.1155\/2013\/183493","DOI":"10.1155\/2013\/183493"},{"key":"1849_CR35","doi-asserted-by":"publisher","first-page":"287","DOI":"10.4103\/0970-9185.74640","volume":"26","author":"P Khanna","year":"2010","unstructured":"Khanna P, Arora M, Sunder R. Adjuvants for intravenous regional anaesthesia. J Anaesthesiol Clin Pharmacol. 2010;26:287. https:\/\/doi.org\/10.4103\/0970-9185.74640.","journal-title":"J Anaesthesiol Clin Pharmacol"},{"key":"1849_CR36","doi-asserted-by":"publisher","first-page":"546","DOI":"10.4103\/0019-5049.72645","volume":"54","author":"K Kulkarni","year":"2010","unstructured":"Kulkarni K, Kadam A, Namazi I. Efficacy of stellate ganglion block with an adjuvant ketamine for peripheral vascular disease of the upper limbs. Indian J Anaesth. 2010;54:546. https:\/\/doi.org\/10.4103\/0019-5049.72645.","journal-title":"Indian J Anaesth"},{"key":"1849_CR37","doi-asserted-by":"publisher","first-page":"17","DOI":"10.4103\/2229-5151.94890","volume":"2","author":"R Goyal","year":"2012","unstructured":"Goyal R, Singh M, Sharma J. Comparison of ketamine with fentanyl as co-induction in propofol anesthesia for short surgical procedures. Int J Crit Illn Inj Sci. 2012;2:17. https:\/\/doi.org\/10.4103\/2229-5151.94890.","journal-title":"Int J Crit Illn Inj Sci"},{"key":"1849_CR38","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1007\/s00540-012-1484-5","volume":"27","author":"MA Erdogan","year":"2013","unstructured":"Erdogan MA, Begec Z, Aydogan MS, Ozgul U, Yucel A, Colak C, et al. Comparison of effects of propofol and ketamine\u2013propofol mixture (ketofol) on laryngeal mask airway insertion conditions and hemodynamics in elderly patients: a randomized, prospective, double-blind trial. J Anesth. 2013;27:12\u20137. https:\/\/doi.org\/10.1007\/s00540-012-1484-5.","journal-title":"J Anesth"},{"key":"1849_CR39","doi-asserted-by":"publisher","first-page":"465","DOI":"10.4103\/0970-9185.74586","volume":"26","author":"S Shakya","year":"2010","unstructured":"Shakya S, Chaturvedi A, Sah BP. Prophylactic low dose ketamine and ondansetron for prevention of shivering during spinal anaesthesia. J Anaesthesiol Clin Pharmacol. 2010;26:465\u20139.","journal-title":"J Anaesthesiol Clin Pharmacol"},{"key":"1849_CR40","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.egja.2010.12.002","volume":"27","author":"MM Kamal","year":"2011","unstructured":"Kamal MM, Hussein NS. Prevention of postspinal shivering by using ketamine plus midazolam in comparison with nefopam. Egypt J Anaesth. 2011;27:1\u20135. https:\/\/doi.org\/10.1016\/j.egja.2010.12.002.","journal-title":"Egypt J Anaesth"},{"key":"1849_CR41","doi-asserted-by":"publisher","first-page":"247","DOI":"10.1016\/j.ejogrb.2013.06.026","volume":"170","author":"S Atashkhoyi","year":"2013","unstructured":"Atashkhoyi S, Negargar S, Hatami-Marandi P. Effects of the addition of low-dose ketamine to propofol-fentanyl anaesthesia during diagnostic gynaecological laparoscopy. Eur J Obstet Gynecol Reproductive Biology. 2013;170:247\u201350. https:\/\/doi.org\/10.1016\/j.ejogrb.2013.06.026.","journal-title":"Eur J Obstet Gynecol Reproductive Biology"},{"key":"1849_CR42","doi-asserted-by":"publisher","first-page":"145","DOI":"10.4103\/0019-5049.96313","volume":"56","author":"S Khutia","year":"2012","unstructured":"Khutia S, Mandal M, Das S, Basu S. Intravenous infusion of ketamine-propofol can be an alternative to intravenous infusion of fentanyl-propofol for deep sedation and analgesia in paediatric patients undergoing emergency short surgical procedures. Indian J Anaesth. 2012;56:145. https:\/\/doi.org\/10.4103\/0019-5049.96313.","journal-title":"Indian J Anaesth"},{"key":"1849_CR43","doi-asserted-by":"publisher","first-page":"904","DOI":"10.1213\/01.ANE.0000159377.15687.87","volume":"101","author":"F Saricaoglu","year":"2005","unstructured":"Saricaoglu F, Dal D, Salman AE, Doral MN, Kln?? K. Aypar ??Lk?? Ketamine Sedation During Spinal Anesthesia for Arthroscopic Knee Surgery Reduced the Ischemia-Reperfusion Injury Markers. Anesth Analgesia. 2005;101:904\u20139. https:\/\/doi.org\/10.1213\/01.ANE.0000159377.15687.87.","journal-title":"Anesth Analgesia"},{"key":"1849_CR44","doi-asserted-by":"publisher","first-page":"e14464","DOI":"10.1111\/cns.14464","volume":"30","author":"L Zhou","year":"2024","unstructured":"Zhou L, Duan J. The role of NMDARs in the anesthetic and antidepressant effects of ketamine. CNS Neurosci Ther. 2024;30:e14464. https:\/\/doi.org\/10.1111\/cns.14464.","journal-title":"CNS Neurosci Ther"},{"key":"1849_CR45","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1097\/YCT.0b013e31824f8296","volume":"28","author":"CG Abdallah","year":"2012","unstructured":"Abdallah CG, Fasula M, Kelmendi B, Sanacora G, Ostroff R. Rapid Antidepressant Effect of Ketamine in the Electroconvulsive Therapy Setting. J ECT. 2012;28:157\u201361. https:\/\/doi.org\/10.1097\/YCT.0b013e31824f8296.","journal-title":"J ECT"},{"key":"1849_CR46","doi-asserted-by":"publisher","first-page":"599721","DOI":"10.3389\/fphar.2020.599721","volume":"11","author":"C Culp","year":"2021","unstructured":"Culp C, Kim HK, Abdi S. Ketamine Use for Cancer and Chronic Pain Management. Front Pharmacol. 2021;11:599721. https:\/\/doi.org\/10.3389\/fphar.2020.599721.","journal-title":"Front Pharmacol"},{"key":"1849_CR47","doi-asserted-by":"publisher","first-page":"e674","DOI":"10.1097\/PR9.0000000000000674","volume":"3","author":"RF Bell","year":"2018","unstructured":"Bell RF, Kalso EA. Ketamine for pain management. PR9. 2018;3:e674. https:\/\/doi.org\/10.1097\/PR9.0000000000000674.","journal-title":"PR9"},{"key":"1849_CR48","doi-asserted-by":"publisher","first-page":"1711","DOI":"10.12688\/f1000research.11372.1","volume":"6","author":"K Jonkman","year":"2017","unstructured":"Jonkman K, Dahan A, Van De Donk T, Aarts L, Niesters M, Van Velzen M. Ketamine for pain. F1000Res. 2017;6:1711. https:\/\/doi.org\/10.12688\/f1000research.11372.1.","journal-title":"F1000Res"},{"key":"1849_CR49","doi-asserted-by":"publisher","DOI":"10.7759\/cureus.53365","author":"A Fa\u00edsco","year":"2024","unstructured":"Fa\u00edsco A, Dinis R, Seixas T, Lopes L. Ketamine in Chronic Pain: A Review. Cureus [Internet]. 2024. https:\/\/doi.org\/10.7759\/cureus.53365. [cited 2025 Sept 14].","journal-title":"Cureus [Internet]"},{"key":"1849_CR50","doi-asserted-by":"publisher","first-page":"7699","DOI":"10.3390\/jcm13247699","volume":"13","author":"D Viderman","year":"2024","unstructured":"Viderman D, Mukazhan D, Kapessova K, Tungushpayev M, Badenes R. The Impact of Ketamine on Outcomes in Acute Pain Management: An Umbrella Review. JCM. 2024;13:7699. https:\/\/doi.org\/10.3390\/jcm13247699.","journal-title":"JCM"},{"key":"1849_CR51","doi-asserted-by":"publisher","unstructured":"Cohen SP, Bhatia A, Buvanendran A, Schwenk ES, Wasan AD, Hurley RW, et al Consensus guidelines on the use of intravenous ketamine infusions for chronic pain from the American Society of regional anesthesia and pain medicine, the American academy of pain medicine, and the American society of anesthesiologists. Reg Anesth Pain Med. 2018;1. https:\/\/doi.org\/10.1097\/AAP.0000000000000808.","DOI":"10.1097\/AAP.0000000000000808"},{"key":"1849_CR52","doi-asserted-by":"publisher","first-page":"421","DOI":"10.1136\/rapm-2023-105035","volume":"50","author":"A Elyn","year":"2025","unstructured":"Elyn A, Roussin A, Lestrade C, Franchitto N, Jullian B, Cantagrel N. Low-dose ketamine infusion to facilitate opioid tapering in chronic non-cancer pain with opioid-use disorder: a historical cohort study. Reg Anesth Pain Med. 2025;50:421\u20138. https:\/\/doi.org\/10.1136\/rapm-2023-105035.","journal-title":"Reg Anesth Pain Med"},{"key":"1849_CR53","doi-asserted-by":"publisher","first-page":"389","DOI":"10.36076\/ppj.2010\/13\/389","volume":"13","author":"L Kapural","year":"2010","unstructured":"Kapural L, Kapural M, Bensitel T, Sessler DI. Opioid-sparing effect of intravenous outpatient ketamine infusions appears short-lived in chronic-pain patients with high opioid requirements. Pain Physician. 2010;13:389\u201394.","journal-title":"Pain Physician"},{"key":"1849_CR54","doi-asserted-by":"publisher","unstructured":"Jin-Feng W, Ming-Yue G, Huan Y, Qin Y, Wei C. Advances in the therapeutic effects of ketamine on cancer pain related depression. Transl Perioper Pain Med [Internet]. 2024 [cited 2025 Sept 14];11. https:\/\/doi.org\/10.31480\/2330-4871\/192","DOI":"10.31480\/2330-4871\/192"},{"key":"1849_CR55","doi-asserted-by":"publisher","first-page":"178","DOI":"10.1016\/0006-8993(94)91538-5","volume":"633","author":"KA Trujillo","year":"1994","unstructured":"Trujillo KA, Akil H. Inhibition of opiate tolerance by non-competitive N-d-aspartate receptor antagonists. Brain Res. 1994;633:178\u201388. https:\/\/doi.org\/10.1016\/0006-8993(94)91538-5.","journal-title":"Brain Res"},{"key":"1849_CR56","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1016\/j.neuropharm.2011.08.044","volume":"62","author":"RS Duman","year":"2012","unstructured":"Duman RS, Li N, Liu R-J, Duric V, Aghajanian G. Signaling pathways underlying the rapid antidepressant actions of ketamine. Neuropharmacology. 2012;62:35\u201341. https:\/\/doi.org\/10.1016\/j.neuropharm.2011.08.044.","journal-title":"Neuropharmacology"},{"key":"1849_CR57","doi-asserted-by":"publisher","first-page":"474","DOI":"10.1002\/hipo.22384","volume":"25","author":"C Chang","year":"2015","unstructured":"Chang C, Hsiao Y, Chen Y, Yu Y, Gean P. Social isolation-induced increase in NMDA receptors in the hippocampus exacerbates emotional dysregulation in mice. Hippocampus. 2015;25:474\u201385. https:\/\/doi.org\/10.1002\/hipo.22384.","journal-title":"Hippocampus"},{"key":"1849_CR58","doi-asserted-by":"publisher","first-page":"1495","DOI":"10.1097\/00000539-200112000-00031","volume":"93","author":"E Sarton","year":"2001","unstructured":"Sarton E, Teppema LJ, Olievier C, Nieuwenhuijs D, Matthes HWD, Kieffer BL, et al. The Involvement of the \u00b5-Opioid Receptor in Ketamine-Induced Respiratory Depression and Antinociception. Anesth Analgesia. 2001;93:1495\u2013500. https:\/\/doi.org\/10.1097\/00000539-200112000-00031.","journal-title":"Anesth Analgesia"},{"key":"1849_CR59","doi-asserted-by":"publisher","first-page":"253","DOI":"10.1016\/0304-3959(85)90089-2","volume":"21","author":"DJ Smith","year":"1985","unstructured":"Smith DJ, Perrotti JM, Mansell AL, Monroe PJ. Ketamine analgesia is not related to an opiate action in the periaqueductal gray region of the rat brain. Pain. 1985;21:253\u201365. https:\/\/doi.org\/10.1016\/0304-3959(85)90089-2.","journal-title":"Pain"},{"key":"1849_CR60","doi-asserted-by":"publisher","first-page":"1010","DOI":"10.1093\/bja\/aes578","volume":"110","author":"M Niesters","year":"2013","unstructured":"Niesters M, Aarts L, Sarton E, Dahan A. Influence of ketamine and morphine on descending pain modulation in chronic pain patients: a randomized placebo-controlled cross-over proof-of-concept study. Br J Anaesth. 2013;110:1010\u20136. https:\/\/doi.org\/10.1093\/bja\/aes578.","journal-title":"Br J Anaesth"},{"key":"1849_CR61","doi-asserted-by":"publisher","first-page":"877","DOI":"10.1038\/sj.mp.4001682","volume":"10","author":"P Seeman","year":"2005","unstructured":"Seeman P, Ko F, Tallerico T. Dopamine receptor contribution to the action of PCP, LSD and ketamine psychotomimetics. Mol Psychiatry. 2005;10:877\u201383. https:\/\/doi.org\/10.1038\/sj.mp.4001682.","journal-title":"Mol Psychiatry"},{"key":"1849_CR62","doi-asserted-by":"publisher","first-page":"313","DOI":"10.1007\/978-3-540-74806-9_15","volume-title":"Modern Anesthetics [Internet]","author":"B Sinner","year":"2008","unstructured":"Sinner B, Graf BM. Ketamine. In: Sch\u00fcttler J, Schwilden H, editors. Modern Anesthetics [Internet]. Berlin, Heidelberg: Springer Berlin Heidelberg; 2008. pp. 313\u201333. [cited 2026 Jan 29]. https:\/\/doi.org\/10.1007\/978-3-540-74806-9_15."},{"key":"1849_CR63","doi-asserted-by":"publisher","first-page":"76","DOI":"10.1016\/j.tacc.2014.03.002","volume":"4","author":"J Sleigh","year":"2014","unstructured":"Sleigh J, Harvey M, Voss L, Denny B. Ketamine \u2013 More mechanisms of action than just NMDA blockade. Trends Anaesth Crit Care. 2014;4:76\u201381. https:\/\/doi.org\/10.1016\/j.tacc.2014.03.002.","journal-title":"Trends Anaesth Crit Care"},{"key":"1849_CR64","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1016\/j.jatmed.2024.10.005","volume":"3","author":"MS Bodnar","year":"2024","unstructured":"Bodnar MS, Barber S, Jim HSL, Huang J. The role of ketamine and its enantiomer in managing depression and pain in cancer patients: A narrative review. J Anesth Translational Med. 2024;3:155\u201365. https:\/\/doi.org\/10.1016\/j.jatmed.2024.10.005.","journal-title":"J Anesth Translational Med"},{"key":"1849_CR65","doi-asserted-by":"publisher","first-page":"428","DOI":"10.1176\/appi.ajp.2019.19020172","volume":"176","author":"V Popova","year":"2019","unstructured":"Popova V, Daly EJ, Trivedi M, Cooper K, Lane R, Lim P, et al. Efficacy and Safety of Flexibly Dosed Esketamine Nasal Spray Combined With a Newly Initiated Oral Antidepressant in Treatment-Resistant Depression: A Randomized Double-Blind Active-Controlled Study. AJP. 2019;176:428\u201338. https:\/\/doi.org\/10.1176\/appi.ajp.2019.19020172.","journal-title":"AJP"},{"key":"1849_CR66","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1159\/000510703","volume":"90","author":"C Gastaldon","year":"2021","unstructured":"Gastaldon C, Raschi E, Kane JM, Barbui C, Schoretsanitis G. Post-Marketing Safety Concerns with Esketamine: A Disproportionality Analysis of Spontaneous Reports Submitted to the FDA Adverse Event Reporting System. Psychother Psychosom. 2021;90:41\u20138. https:\/\/doi.org\/10.1159\/000510703.","journal-title":"Psychother Psychosom"},{"key":"1849_CR67","doi-asserted-by":"publisher","first-page":"1505","DOI":"10.1111\/pme.12182","volume":"14","author":"AL Bredlau","year":"2013","unstructured":"Bredlau AL, Thakur R, Korones DN, Dworkin RH. Ketamine for Pain in Adults and Children with Cancer: A Systematic Review and Synthesis of the Literature. Pain Med. 2013;14:1505\u201317. https:\/\/doi.org\/10.1111\/pme.12182.","journal-title":"Pain Med"},{"key":"1849_CR68","doi-asserted-by":"publisher","first-page":"190","DOI":"10.31480\/2330-4871\/112","volume":"7","author":"C Bohringer","year":"2020","unstructured":"Bohringer C, Copeland D, Liu H. A Contemporary Approach to the Treatment of Perioperative Bronchospasm. Transl Perioper Pain Med. 2020;7:190\u20138. https:\/\/doi.org\/10.31480\/2330-4871\/112.","journal-title":"Transl Perioper Pain Med"},{"key":"1849_CR69","doi-asserted-by":"publisher","first-page":"54","DOI":"10.1186\/s42358-024-00393-9","volume":"64","author":"JF De Carvalho","year":"2024","unstructured":"De Carvalho JF, De Sena EP. Ketamine in fibromyalgia: a systematic review. Adv Rheumatol. 2024;64:54. https:\/\/doi.org\/10.1186\/s42358-024-00393-9.","journal-title":"Adv Rheumatol"},{"key":"1849_CR70","doi-asserted-by":"publisher","first-page":"1165","DOI":"10.3390\/ph17091165","volume":"17","author":"A Bruna-Mejias","year":"2024","unstructured":"Bruna-Mejias A, Baeza V, Gamboa J, Baez Flores B, San Martin J, Astorga C, et al. Use of Ketamine in Patients with Multifactorial Neuropathic Pain: A Systematic Review and Meta-Analysis. Pharmaceuticals. 2024;17:1165. https:\/\/doi.org\/10.3390\/ph17091165.","journal-title":"Pharmaceuticals"},{"key":"1849_CR71","first-page":"298","volume":"72","author":"SH Kim","year":"2007","unstructured":"Kim SH, Park SK, Kim HJ, Kim CK, Lee NS, Won JH, et al. The effect of ketamine as adjuvant to opioid for intractable cancer pain. Korean J Med Korean J Med. 2007;72:298\u2013305.","journal-title":"Korean J Med Korean J Med"},{"key":"1849_CR72","doi-asserted-by":"publisher","first-page":"331","DOI":"10.1016\/j.pbb.2010.02.009","volume":"95","author":"D Pascual","year":"2010","unstructured":"Pascual D, Goicoechea C, Burgos E, Mart\u00edn MI. Antinociceptive effect of three common analgesic drugs on peripheral neuropathy induced by paclitaxel in rats. Pharmacol Biochem Behav. 2010;95:331\u20137. https:\/\/doi.org\/10.1016\/j.pbb.2010.02.009.","journal-title":"Pharmacol Biochem Behav"},{"key":"1849_CR73","doi-asserted-by":"publisher","first-page":"66","DOI":"10.4097\/kjae.2012.62.1.66","volume":"62","author":"B-Y Hwang","year":"2012","unstructured":"Hwang B-Y, Kim E-S, Kim C-H, Kwon J-Y, Kim H-K. Gender differences in paclitaxel-induced neuropathic pain behavior and analgesic response in rats. Korean J Anesthesiol. 2012;62:66\u201372. https:\/\/doi.org\/10.4097\/kjae.2012.62.1.66.","journal-title":"Korean J Anesthesiol"},{"key":"1849_CR74","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1016\/0006-8993(95)01452-7","volume":"715","author":"J Qian","year":"1996","unstructured":"Qian J, Brown SD, Carlton SM. Systemic ketamine attenuates nociceptive behaviors in a rat model of peripheral neuropathy. Brain Res. 1996;715:51\u201362. https:\/\/doi.org\/10.1016\/0006-8993(95)01452-7.","journal-title":"Brain Res"},{"key":"1849_CR75","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1016\/s0304-3959(00)00423-1","volume":"91","author":"R Suzuki","year":"2001","unstructured":"Suzuki R, Matthews EA, Dickenson AH. Comparison of the effects of MK-801, ketamine and memantine on responses of spinal dorsal horn neurones in a rat model of mononeuropathy. Pain. 2001;91:101\u20139. https:\/\/doi.org\/10.1016\/s0304-3959(00)00423-1.","journal-title":"Pain"},{"key":"1849_CR76","doi-asserted-by":"publisher","first-page":"52","DOI":"10.4097\/kjae.2014.66.1.52","volume":"66","author":"S-Y Kwon","year":"2014","unstructured":"Kwon S-Y, Yeom JH, Joo J-D. Ketamine reduces the induced spinal p38 MAPK and pro-inflammatory cytokines in a neuropathic rats. Korean J Anesthesiol. 2014;66:52\u20138. https:\/\/doi.org\/10.4097\/kjae.2014.66.1.52.","journal-title":"Korean J Anesthesiol"},{"key":"1849_CR77","doi-asserted-by":"publisher","first-page":"482","DOI":"10.1097\/AAP.0000000000000416","volume":"41","author":"ES Schwenk","year":"2016","unstructured":"Schwenk ES, Goldberg SF, Patel RD, Zhou J, Adams DR, Baratta JL, et al. Adverse Drug Effects and Preoperative Medication Factors Related to Perioperative Low-Dose Ketamine Infusions. Reg Anesth Pain Med. 2016;41:482\u20137. https:\/\/doi.org\/10.1097\/AAP.0000000000000416.","journal-title":"Reg Anesth Pain Med"},{"key":"1849_CR78","doi-asserted-by":"publisher","first-page":"208","DOI":"10.1016\/s1098-7339(99)90129-3","volume":"24","author":"AW Burton","year":"1999","unstructured":"Burton AW, Lee DH, Saab C, Chung JM. Preemptive intrathecal ketamine injection produces a long-lasting decrease in neuropathic pain behaviors in a rat model. Reg Anesth Pain Med. 1999;24:208\u201313. https:\/\/doi.org\/10.1016\/s1098-7339(99)90129-3.","journal-title":"Reg Anesth Pain Med"},{"key":"1849_CR79","doi-asserted-by":"publisher","first-page":"698","DOI":"10.1016\/j.jpainsymman.2008.03.018","volume":"37","author":"SP Cohen","year":"2009","unstructured":"Cohen SP, Wang S, Chen L, Kurihara C, McKnight G, Marcuson M, et al. An intravenous ketamine test as a predictive response tool in opioid-exposed patients with persistent pain. J Pain Symptom Manage. 2009;37:698\u2013708. https:\/\/doi.org\/10.1016\/j.jpainsymman.2008.03.018.","journal-title":"J Pain Symptom Manage"},{"key":"1849_CR80","doi-asserted-by":"publisher","first-page":"50","DOI":"10.1186\/1744-8069-6-50","volume":"6","author":"X-P Mei","year":"2010","unstructured":"Mei X-P, Wang W, Wang W, Zhu C, Chen L, Zhang T, et al. Combining ketamine with astrocytic inhibitor as a potential analgesic strategy for neuropathic pain ketamine, astrocytic inhibitor and pain. Mol Pain. 2010;6:50. https:\/\/doi.org\/10.1186\/1744-8069-6-50.","journal-title":"Mol Pain"},{"key":"1849_CR81","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1159\/000324293","volume":"19","author":"X-P Mei","year":"2011","unstructured":"Mei X-P, Zhou Y, Wang W, Tang J, Wang W, Zhang H, et al. Ketamine depresses toll-like receptor 3 signaling in spinal microglia in a rat model of neuropathic pain. Neurosignals. 2011;19:44\u201353. https:\/\/doi.org\/10.1159\/000324293.","journal-title":"Neurosignals"},{"key":"1849_CR82","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1186\/1742-2094-8-6","volume":"8","author":"X-P Mei","year":"2011","unstructured":"Mei X-P, Zhang H, Wang W, Wei Y-Y, Zhai M-Z, Wang W, et al. Inhibition of spinal astrocytic c-Jun N-terminal kinase (JNK) activation correlates with the analgesic effects of ketamine in neuropathic pain. J Neuroinflammation. 2011;8:6. https:\/\/doi.org\/10.1186\/1742-2094-8-6.","journal-title":"J Neuroinflammation"},{"key":"1849_CR83","doi-asserted-by":"publisher","first-page":"573","DOI":"10.17219\/acem\/94143","volume":"28","author":"ND Doncheva","year":"2019","unstructured":"Doncheva ND, Vasileva L, Saracheva K, Dimitrova D, Getova D. Study of antinociceptive effect of ketamine in acute and neuropathic pain models in rats. Adv Clin Exp Med. 2019;28:573\u20139. https:\/\/doi.org\/10.17219\/acem\/94143.","journal-title":"Adv Clin Exp Med"},{"key":"1849_CR84","doi-asserted-by":"publisher","first-page":"479","DOI":"10.1016\/j.pbb.2006.06.011","volume":"84","author":"KCP Vissers","year":"2006","unstructured":"Vissers KCP, Geenen F, Biermans R, Meert TF. Pharmacological correlation between the formalin test and the neuropathic pain behavior in different species with chronic constriction injury. Pharmacol Biochem Behav. 2006;84:479\u201386. https:\/\/doi.org\/10.1016\/j.pbb.2006.06.011.","journal-title":"Pharmacol Biochem Behav"},{"key":"1849_CR85","doi-asserted-by":"publisher","first-page":"1753","DOI":"10.1213\/01.ANE.0000136953.11583.7B","volume":"99","author":"SP Cohen","year":"2004","unstructured":"Cohen SP, Chang AS, Larkin T, Mao J. The intravenous ketamine test: a predictive response tool for oral dextromethorphan treatment in neuropathic pain. Anesth Analg. 2004;99:1753\u20139. https:\/\/doi.org\/10.1213\/01.ANE.0000136953.11583.7B.","journal-title":"Anesth Analg"},{"key":"1849_CR86","doi-asserted-by":"publisher","first-page":"165","DOI":"10.1097\/ALN.0b013e31821bdb9b","volume":"115","author":"M Swartjes","year":"2011","unstructured":"Swartjes M, Morariu A, Niesters M, Aarts L, Dahan A. Nonselective and NR2B-selective N-methyl-D-aspartic acid receptor antagonists produce antinociception and long-term relief of allodynia in acute and neuropathic pain. Anesthesiology. 2011;115:165\u201374. https:\/\/doi.org\/10.1097\/ALN.0b013e31821bdb9b.","journal-title":"Anesthesiology"},{"key":"1849_CR87","doi-asserted-by":"publisher","first-page":"812","DOI":"10.1097\/ALN.0b013e31822f16ae","volume":"115","author":"J Wang","year":"2011","unstructured":"Wang J, Goffer Y, Xu D, Tukey DS, Shamir DB, Eberle SE, et al. A single subanesthetic dose of ketamine relieves depression-like behaviors induced by neuropathic pain in rats. Anesthesiology. 2011;115:812\u201321. https:\/\/doi.org\/10.1097\/ALN.0b013e31822f16ae.","journal-title":"Anesthesiology"},{"key":"1849_CR88","doi-asserted-by":"publisher","first-page":"1781","DOI":"10.1111\/pme.12735","volume":"16","author":"P Mak","year":"2015","unstructured":"Mak P, Broadbear JH, Kolosov A, Goodchild CS. Long-Term Antihyperalgesic and Opioid-Sparing Effects of 5-Day Ketamine and Morphine Infusion (Burst Ketamine) in Diabetic Neuropathic Rats. Pain Med. 2015;16:1781\u201393. https:\/\/doi.org\/10.1111\/pme.12735.","journal-title":"Pain Med"},{"key":"1849_CR89","doi-asserted-by":"publisher","first-page":"238","DOI":"10.11607\/ofph.1973","volume":"32","author":"R Claudino","year":"2018","unstructured":"Claudino R, Nones C, Araya E, Chichorro J. Analgesic Effects of Intranasal Ketamine in Rat Models of Facial Pain. J Oral Facial Pain Headache. 2018;32:238\u2013346. https:\/\/doi.org\/10.11607\/ofph.1973.","journal-title":"J Oral Facial Pain Headache"},{"key":"1849_CR90","doi-asserted-by":"publisher","first-page":"474","DOI":"10.1016\/j.bbi.2009.12.002","volume":"24","author":"MK Boettger","year":"2010","unstructured":"Boettger MK, Weber K, Gajda M, Br\u00e4uer R, Schaible H-G, Brain. Behav Immun. 2010;24:474\u201385. https:\/\/doi.org\/10.1016\/j.bbi.2009.12.002.","journal-title":"Behav Immun"},{"key":"1849_CR91","doi-asserted-by":"publisher","first-page":"266","DOI":"10.1254\/jphs.08154FP","volume":"108","author":"A Sasaki","year":"2008","unstructured":"Sasaki A, Serizawa K, Andoh T, Shiraki K, Takahata H, Kuraishi Y. Pharmacological Differences Between Static and Dynamic Allodynia in Mice With Herpetic or Postherpetic Pain. J Pharmacol Sci. 2008;108:266\u201373. https:\/\/doi.org\/10.1254\/jphs.08154FP.","journal-title":"J Pharmacol Sci"},{"key":"1849_CR92","doi-asserted-by":"publisher","first-page":"773","DOI":"10.1080\/14737175.2024.2365946","volume":"24","author":"JV Pergolizzi","year":"2024","unstructured":"Pergolizzi JV, LeQuang JA, El-Tallawy SN, Wagner M, Ahmed RS, Varrassi G. An update on pharmacotherapy for trigeminal neuralgia. Expert Rev Neurother. 2024;24:773\u201386. https:\/\/doi.org\/10.1080\/14737175.2024.2365946.","journal-title":"Expert Rev Neurother"},{"key":"1849_CR93","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1016\/S0885-3924(02)00603-6","volume":"25","author":"J Ward","year":"2003","unstructured":"Ward J, Standage C. Angina Pain Precipitated by a Continuous Subcutaneous Infusion of Ketamine. J Pain Symptom Manag. 2003;25:6\u20137. https:\/\/doi.org\/10.1016\/S0885-3924(02)00603-6.","journal-title":"J Pain Symptom Manag"},{"key":"1849_CR94","doi-asserted-by":"publisher","first-page":"263","DOI":"10.1111\/j.1526-4637.2011.01241.x","volume":"13","author":"S Patil","year":"2012","unstructured":"Patil S, Anitescu M. Efficacy of outpatient ketamine infusions in refractory chronic pain syndromes: a 5-year retrospective analysis. Pain Med Malden Mass. 2012;13:263\u20139. https:\/\/doi.org\/10.1111\/j.1526-4637.2011.01241.x.","journal-title":"Pain Med Malden Mass"},{"key":"1849_CR95","doi-asserted-by":"publisher","first-page":"100","DOI":"10.1016\/j.nlm.2015.06.004","volume":"123","author":"M Tajerian","year":"2015","unstructured":"Tajerian M, Sahbaie P, Sun Y, Leu D, Yang HY, Li W, et al. Sex differences in a Murine Model of Complex Regional Pain Syndrome. Neurobiol Learn Mem. 2015;123:100\u20139. https:\/\/doi.org\/10.1016\/j.nlm.2015.06.004.","journal-title":"Neurobiol Learn Mem"},{"key":"1849_CR96","doi-asserted-by":"publisher","first-page":"380403","DOI":"10.1155\/2015\/380403","volume":"2015","author":"S Liman","year":"2015","unstructured":"Liman S, Cheung CW, Wong KL, Tai W, Qiu Q, Ng KF, et al. Preventive Treatment with Ketamine Attenuates the Ischaemia-Reperfusion Response in a Chronic Postischaemia Pain Model. Oxid Med Cell Longev. 2015;2015:380403. https:\/\/doi.org\/10.1155\/2015\/380403.","journal-title":"Oxid Med Cell Longev"},{"key":"1849_CR97","doi-asserted-by":"publisher","first-page":"2315","DOI":"10.1056\/NEJMoa2302399","volume":"388","author":"A Anand","year":"2023","unstructured":"Anand A, Mathew SJ, Sanacora G, Murrough JW, Goes FS, Altinay M, et al. Ketamine versus ECT for Nonpsychotic Treatment-Resistant Major Depression. N Engl J Med. 2023;388:2315\u201325. https:\/\/doi.org\/10.1056\/NEJMoa2302399.","journal-title":"N Engl J Med"},{"key":"1849_CR98","doi-asserted-by":"publisher","first-page":"104902","DOI":"10.1016\/j.ebiom.2023.104902","volume":"99","author":"M Rengasamy","year":"2024","unstructured":"Rengasamy M, Mathew S, Howland R, Griffo A, Panny B, Price R. Neural connectivity moderators and mechanisms of ketamine treatment among treatment-resistant depressed patients: a randomized controlled trial. eBioMedicine. 2024;99:104902. https:\/\/doi.org\/10.1016\/j.ebiom.2023.104902.","journal-title":"eBioMedicine"},{"key":"1849_CR99","doi-asserted-by":"publisher","first-page":"247","DOI":"10.1176\/appi.ajp.20240378","volume":"182","author":"MR Levinstein","year":"2025","unstructured":"Levinstein MR, Budinich RC, Bonaventura J, Schatzberg AF, Zarate CA, Michaelides M. Redefining Ketamine Pharmacology for Antidepressant Action: Synergistic NMDA and Opioid Receptor Interactions? AJP. 2025;182:247\u201358. https:\/\/doi.org\/10.1176\/appi.ajp.20240378.","journal-title":"AJP"},{"key":"1849_CR100","doi-asserted-by":"publisher","first-page":"856","DOI":"10.1001\/archpsyc.63.8.856","volume":"63","author":"CA Zarate","year":"2006","unstructured":"Zarate CA, Singh JB, Carlson PJ, Brutsche NE, Ameli R, Luckenbaugh DA, et al. A Randomized Trial of an N-methyl-D-aspartate Antagonist in Treatment-Resistant Major Depression. Arch Gen Psychiatry. 2006;63:856. https:\/\/doi.org\/10.1001\/archpsyc.63.8.856.","journal-title":"Arch Gen Psychiatry"},{"key":"1849_CR101","doi-asserted-by":"publisher","first-page":"801","DOI":"10.1038\/mp.2017.255","volume":"23","author":"P Zanos","year":"2018","unstructured":"Zanos P, Gould TD. Mechanisms of ketamine action as an antidepressant. Mol Psychiatry. 2018;23:801\u201311. https:\/\/doi.org\/10.1038\/mp.2017.255.","journal-title":"Mol Psychiatry"},{"key":"1849_CR102","doi-asserted-by":"publisher","first-page":"204512532110567","DOI":"10.1177\/20451253211056743","volume":"11","author":"E Whittaker","year":"2021","unstructured":"Whittaker E, Dadabayev AR, Joshi SA, Glue P. Systematic review and meta-analysis of randomized controlled trials of ketamine in the treatment of refractory anxiety spectrum disorders. Therapeutic Adv Psychopharmacol. 2021;11:20451253211056743. https:\/\/doi.org\/10.1177\/20451253211056743.","journal-title":"Therapeutic Adv Psychopharmacol"},{"key":"1849_CR103","doi-asserted-by":"publisher","first-page":"1338581","DOI":"10.3389\/fpsyt.2024.1338581","volume":"15","author":"JJW Liu","year":"2024","unstructured":"Liu JJW, Ein N, Gervasio J, Baker C, Plouffe R, Wanklyn S, et al. Ketamine in the effective management of chronic pain, depression, and posttraumatic stress disorder for Veterans: A meta-analysis and systematic review. Front Psychiatry. 2024;15:1338581. https:\/\/doi.org\/10.3389\/fpsyt.2024.1338581.","journal-title":"Front Psychiatry"},{"key":"1849_CR104","doi-asserted-by":"publisher","first-page":"34","DOI":"10.4266\/acc.2023.00829","volume":"39","author":"Y Abdildin","year":"2024","unstructured":"Abdildin Y, Tapinova K, Nemerenova A, Viderman D. The impact of ketamine on outcomes in critically ill patients: a systematic review with meta-analysis and trial sequential analysis of randomized controlled trials. ACC. 2024;39:34\u201346. https:\/\/doi.org\/10.4266\/acc.2023.00829.","journal-title":"ACC"},{"key":"1849_CR105","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1016\/S2215-0366(17)30272-9","volume":"5","author":"B Short","year":"2018","unstructured":"Short B, Fong J, Galvez V, Shelker W, Loo CK. Side-effects associated with ketamine use in depression: a systematic review. Lancet Psychiatry. 2018;5:65\u201378. https:\/\/doi.org\/10.1016\/S2215-0366(17)30272-9.","journal-title":"Lancet Psychiatry"},{"key":"1849_CR106","doi-asserted-by":"publisher","first-page":"795231","DOI":"10.3389\/fnana.2022.795231","volume":"16","author":"JFM Strous","year":"2022","unstructured":"Strous JFM, Weeland CJ, Van Der Draai FA, Daams JG, Denys D, Lok A, et al. Brain Changes Associated With Long-Term Ketamine Abuse, A Systematic Review. Front Neuroanat. 2022;16:795231. https:\/\/doi.org\/10.3389\/fnana.2022.795231.","journal-title":"Front Neuroanat"},{"key":"1849_CR107","doi-asserted-by":"publisher","first-page":"195","DOI":"10.1002\/jemt.20774","volume":"73","author":"YT Mak","year":"2010","unstructured":"Mak YT, Lam WP, L\u00fc L, Wong YW, Yew DT. The toxic effect of ketamine on SH-SY5Y neuroblastoma cell line and human neuron. Microscopy Res Technique. 2010;73:195\u2013201. https:\/\/doi.org\/10.1002\/jemt.20774.","journal-title":"Microscopy Res Technique"},{"key":"1849_CR108","doi-asserted-by":"publisher","first-page":"597467","DOI":"10.3389\/fgene.2020.597467","volume":"11","author":"T Li","year":"2021","unstructured":"Li T, Yang J, Yang B, Zhao G, Lin H, Liu Q, et al. Ketamine Inhibits Ovarian Cancer Cell Growth by Regulating the lncRNA-PVT1\/EZH2\/p57 Axis. Front Genet. 2021;11:597467. https:\/\/doi.org\/10.3389\/fgene.2020.597467.","journal-title":"Front Genet"},{"key":"1849_CR109","doi-asserted-by":"publisher","first-page":"175580","DOI":"10.1016\/j.ejphar.2023.175580","volume":"945","author":"J Saito","year":"2023","unstructured":"Saito J, Zao H, Wu L, Iwasaki M, Sun Q, Hu C, et al. Anti-cancer effect of ketamine in comparison with MK801 on neuroglioma and lung cancer cells. Eur J Pharmacol. 2023;945:175580. https:\/\/doi.org\/10.1016\/j.ejphar.2023.175580.","journal-title":"Eur J Pharmacol"},{"key":"1849_CR110","doi-asserted-by":"publisher","first-page":"171","DOI":"10.1016\/j.yexmp.2019.02.004","volume":"107","author":"W Duan","year":"2019","unstructured":"Duan W, Hu J, Liu Y. Ketamine inhibits colorectal cancer cells malignant potential via blockage of NMDA receptor. Exp Mol Pathol. 2019;107:171\u20138. https:\/\/doi.org\/10.1016\/j.yexmp.2019.02.004.","journal-title":"Exp Mol Pathol"},{"key":"1849_CR111","doi-asserted-by":"publisher","first-page":"53","DOI":"10.21608\/jcbr.2024.255088.1327","volume":"8","author":"N Hussein","year":"2024","unstructured":"Hussein N, Ahmad M, Ali K. Tramadol and\/or Ketamine Repurposing as Potential Anticancer Drugs in Metastatic Castration-Resistant Prostate Cancer Cell Lines. Int J Cancer Biomedical Res. 2024;8:53\u201363. https:\/\/doi.org\/10.21608\/jcbr.2024.255088.1327.","journal-title":"Int J Cancer Biomedical Res"},{"key":"1849_CR112","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1186\/s12871-015-0076-y","volume":"15","author":"M Malsy","year":"2015","unstructured":"Malsy M, Gebhardt K, Gruber M, Wiese C, Graf B, Bundscherer A. Effects of ketamine, s-ketamine, and MK 801 on proliferation, apoptosis, and necrosis in pancreatic cancer cells. BMC Anesthesiol. 2015;15:111. https:\/\/doi.org\/10.1186\/s12871-015-0076-y.","journal-title":"BMC Anesthesiol"},{"key":"1849_CR113","doi-asserted-by":"publisher","first-page":"1140","DOI":"10.5114\/aoms.2019.85146","volume":"16","author":"S Zhao","year":"2020","unstructured":"Zhao S, Shao L, Wang Y, Meng Q, Yu J. Ketamine exhibits anti-gastric cancer activity via induction of apoptosis and attenuation of PI3K\/Akt\/mTOR. aoms. 2020;16:1140\u20139. https:\/\/doi.org\/10.5114\/aoms.2019.85146.","journal-title":"aoms"},{"key":"1849_CR114","doi-asserted-by":"publisher","first-page":"110","DOI":"10.22514\/ejgo.2024.075","volume":"45","author":"H He","year":"2024","unstructured":"He H, Zhang J, Zhao Y. Ketamine inhibits endometrial cancer cell growth and motility by inducing ferroptosis. EJGO. 2024;45:110. https:\/\/doi.org\/10.22514\/ejgo.2024.075.","journal-title":"EJGO"},{"key":"1849_CR115","doi-asserted-by":"publisher","first-page":"3965","DOI":"10.2147\/DDDT.S332847","volume":"15","author":"G-N He","year":"2021","unstructured":"He G-N, Bao N-R, Wang S, Xi M, Zhang T-H, Chen F-S. Ketamine Induces Ferroptosis of Liver Cancer Cells by Targeting lncRNA PVT1\/miR-214-3p\/GPX4. DDDT. 2021;15:3965\u201378. https:\/\/doi.org\/10.2147\/DDDT.S332847.","journal-title":"DDDT"},{"key":"1849_CR116","doi-asserted-by":"publisher","first-page":"1907","DOI":"10.4238\/2013.January.4.7","volume":"12","author":"H He","year":"2013","unstructured":"He H, Chen J, Xie WP, Cao S, Hu HY, Yang LQ, et al. Ketamine used as an acesodyne in human breast cancer therapy causes an undesirable side effect, upregulating anti-apoptosis protein Bcl-2 expression. Genet Mol Res. 2013;12:1907\u201315. https:\/\/doi.org\/10.4238\/2013.January.4.7.","journal-title":"Genet Mol Res"},{"key":"1849_CR117","doi-asserted-by":"publisher","first-page":"5415","DOI":"10.21873\/anticanres.16745","volume":"43","author":"L-K Chen","year":"2023","unstructured":"Chen L-K, Chen S-S, Shih C-H, Huang Z-X, Chen L, Chen K-B. Ketamine Promoted Breast Cancer Invasion and Metastasis Through Up-regulating Wnt, BMP, and EGFR Signaling. Anticancer Res. 2023;43:5415\u201324. https:\/\/doi.org\/10.21873\/anticanres.16745.","journal-title":"Anticancer Res"},{"key":"1849_CR118","doi-asserted-by":"publisher","first-page":"539","DOI":"10.1146\/annurev-immunol-032414-112049","volume":"34","author":"SH Baumeister","year":"2016","unstructured":"Baumeister SH, Freeman GJ, Dranoff G, Sharpe AH. Coinhibitory Pathways in Immunotherapy for Cancer. Annu Rev Immunol. 2016;34:539\u201373. https:\/\/doi.org\/10.1146\/annurev-immunol-032414-112049.","journal-title":"Annu Rev Immunol"},{"key":"1849_CR119","doi-asserted-by":"publisher","first-page":"306","DOI":"10.1016\/j.jss.2016.02.031","volume":"203","author":"M Hou","year":"2016","unstructured":"Hou M, Zhou N-B, Li H, Wang B-S, Wang X-Q, Wang X-W, et al. Morphine and ketamine inhibit immune function of gastric cancer patients by increasing percentage of CD4\u2009+\u2009CD25\u2009+\u2009Foxp3\u2009+\u2009regulatory T cells in vitro. J Surg Res. 2016;203:306\u201312. https:\/\/doi.org\/10.1016\/j.jss.2016.02.031.","journal-title":"J Surg Res"},{"key":"1849_CR120","doi-asserted-by":"publisher","DOI":"10.3892\/etm.2018.7035","author":"M Hou","year":"2018","unstructured":"Hou M, Zhou N, Li H, Wang B, Wang X, Wang X, et al. Morphine and ketamine treatment suppress the differentiation of T helper cells of patients with colorectal cancer in vitro. Exp Ther Med [Internet]. 2018. https:\/\/doi.org\/10.3892\/etm.2018.7035. [cited 2025 Oct 17].","journal-title":"Exp Ther Med [Internet]"},{"key":"1849_CR121","doi-asserted-by":"publisher","first-page":"683","DOI":"10.1007\/s12630-021-01925-3","volume":"68","author":"JS Cho","year":"2021","unstructured":"Cho JS, Kim NY, Shim J-K, Jun JH, Lee S, Kwak Y-L. The immunomodulatory effect of ketamine in colorectal cancer surgery: a randomized-controlled trial. Can J Anesth\/J Can Anesth. 2021;68:683\u201392. https:\/\/doi.org\/10.1007\/s12630-021-01925-3.","journal-title":"Can J Anesth\/J Can Anesth"},{"key":"1849_CR122","doi-asserted-by":"publisher","first-page":"1128924","DOI":"10.3389\/fphar.2023.1128924","volume":"14","author":"J Zhang","year":"2023","unstructured":"Zhang J, Ma Q, Li W, Li X, Chen X. S-Ketamine attenuates inflammatory effect and modulates the immune response in patients undergoing modified radical mastectomy: A prospective randomized controlled trial. Front Pharmacol. 2023;14:1128924. https:\/\/doi.org\/10.3389\/fphar.2023.1128924.","journal-title":"Front Pharmacol"},{"key":"1849_CR123","doi-asserted-by":"publisher","first-page":"788","DOI":"10.1002\/cam4.1288","volume":"7","author":"X Zhou","year":"2018","unstructured":"Zhou X, Zhang P, Luo W, Zhang L, Hu R, Sun Y, et al. Ketamine induces apoptosis in lung adenocarcinoma cells by regulating the expression of CD 69. Cancer Med. 2018;7:788\u201395. https:\/\/doi.org\/10.1002\/cam4.1288.","journal-title":"Cancer Med"},{"key":"1849_CR124","doi-asserted-by":"publisher","unstructured":"Jiang Y, Li T, Qian Y, Zuo X, Liu J. Morphine in combination with ketamine improves cervical cancer pain and suppresses immune function via the JAK3\/STAT5 Pathway. Varrassi G, editor. Pain Research and Management. 2022;2022:1\u20139. https:\/\/doi.org\/10.1155\/2022\/9364365","DOI":"10.1155\/2022\/9364365"}],"container-title":["Current Oncology Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11912-026-01849-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11912-026-01849-5","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11912-026-01849-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T23:03:31Z","timestamp":1792796611000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11912-026-01849-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,10,23]]},"references-count":124,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["1849"],"URL":"https:\/\/doi.org\/10.1007\/s11912-026-01849-5","relation":{},"ISSN":["1534-6269"],"issn-type":[{"value":"1534-6269","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,10,23]]},"assertion":[{"value":"11 September 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 October 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 October 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","label":"Competing Interests","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"109"}}